AU2004318681A1 - Nucleic acid based assays for identification of FC receptor polymorphisms - Google Patents
Nucleic acid based assays for identification of FC receptor polymorphisms Download PDFInfo
- Publication number
- AU2004318681A1 AU2004318681A1 AU2004318681A AU2004318681A AU2004318681A1 AU 2004318681 A1 AU2004318681 A1 AU 2004318681A1 AU 2004318681 A AU2004318681 A AU 2004318681A AU 2004318681 A AU2004318681 A AU 2004318681A AU 2004318681 A1 AU2004318681 A1 AU 2004318681A1
- Authority
- AU
- Australia
- Prior art keywords
- primers
- genotype
- nucleic acids
- combination
- oligonucleotides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- General Engineering & Computer Science (AREA)
- Hospice & Palliative Care (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56064904P | 2004-04-07 | 2004-04-07 | |
US60/560,649 | 2004-04-07 | ||
PCT/US2004/043726 WO2005102379A2 (en) | 2004-04-07 | 2004-12-22 | Nucleic acid based assays for identification of fc receptor polymorphisms |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2004318681A1 true AU2004318681A1 (en) | 2005-11-03 |
Family
ID=35197498
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2004318681A Abandoned AU2004318681A1 (en) | 2004-04-07 | 2004-12-22 | Nucleic acid based assays for identification of FC receptor polymorphisms |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1732939A4 (pt) |
JP (1) | JP2007532110A (pt) |
KR (1) | KR20070004082A (pt) |
CN (1) | CN1976942A (pt) |
AU (1) | AU2004318681A1 (pt) |
BR (1) | BRPI0418722A (pt) |
CA (1) | CA2562016A1 (pt) |
IL (1) | IL178333A0 (pt) |
RU (1) | RU2006138865A (pt) |
WO (1) | WO2005102379A2 (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090181016A1 (en) * | 2005-11-30 | 2009-07-16 | University Of Southern California | FCgamma POLYMORPHISMS FOR PREDICTING DISEASE AND TREATMENT OUTCOME |
EP2109686A2 (en) | 2007-01-18 | 2009-10-21 | University Of Southern California | Genetic markers for predicting responsiveness to combination therapy |
WO2009026502A1 (en) * | 2007-08-22 | 2009-02-26 | Wyeth | Nested pcr-based method for specific genotyping of the fc-gamma receptor iiia gene |
JP2016534749A (ja) * | 2013-10-15 | 2016-11-10 | コネクシオ ゲノミクス ピーティーワイ リミテッド | 主要組織適合遺伝子複合体一塩基多型 |
WO2021146521A1 (en) * | 2020-01-16 | 2021-07-22 | Acepodia Biotechnologies Ltd. | A novel cd16+ natural killer cell and a method of culturing cd16+ natural killer cell |
CN114277149B (zh) * | 2021-12-30 | 2023-09-22 | 苏州方科生物科技有限公司 | 一种检测cd16a基因多态性的试剂盒及其应用和使用方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5639611A (en) * | 1988-12-12 | 1997-06-17 | City Of Hope | Allele specific polymerase chain reaction |
AU2002346999B2 (en) * | 2001-10-19 | 2007-11-08 | Centre Hospitalier Regional Et Universitaire De Tours | Methods and compositions to evaluate antibody treatment response |
-
2004
- 2004-12-22 EP EP04815738A patent/EP1732939A4/en not_active Withdrawn
- 2004-12-22 CA CA002562016A patent/CA2562016A1/en not_active Abandoned
- 2004-12-22 BR BRPI0418722-9A patent/BRPI0418722A/pt not_active IP Right Cessation
- 2004-12-22 JP JP2007507303A patent/JP2007532110A/ja active Pending
- 2004-12-22 RU RU2006138865/13A patent/RU2006138865A/ru not_active Application Discontinuation
- 2004-12-22 WO PCT/US2004/043726 patent/WO2005102379A2/en active Application Filing
- 2004-12-22 KR KR1020067022960A patent/KR20070004082A/ko not_active Application Discontinuation
- 2004-12-22 AU AU2004318681A patent/AU2004318681A1/en not_active Abandoned
- 2004-12-22 CN CNA2004800428432A patent/CN1976942A/zh active Pending
-
2006
- 2006-09-27 IL IL178333A patent/IL178333A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2007532110A (ja) | 2007-11-15 |
EP1732939A2 (en) | 2006-12-20 |
EP1732939A4 (en) | 2008-09-17 |
CN1976942A (zh) | 2007-06-06 |
RU2006138865A (ru) | 2008-05-20 |
KR20070004082A (ko) | 2007-01-05 |
IL178333A0 (en) | 2007-02-11 |
WO2005102379A2 (en) | 2005-11-03 |
CA2562016A1 (en) | 2005-11-03 |
BRPI0418722A (pt) | 2007-09-11 |
WO2005102379A3 (en) | 2006-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10801078B2 (en) | Methods and compositions for detecting BK virus | |
WO2012061814A1 (en) | Pcr primers and methods for rapid and specific genotyping | |
US20210011019A1 (en) | Mpl mutations in jak2 v617f negative patients with myeloproliferative disease | |
AU2015358251A1 (en) | Methods and reagents for detecting neisseria gonorrhoeae and its antimicrobial resistance determinants | |
CZ20033516A3 (cs) | Diagnostické zkoušky pro parvovirus B19 | |
MXPA04012501A (es) | Identificacion de oligonucleotidos para la captura, deteccion y cuatificacion de acido nucleico viral de la hepatitis a. | |
AU2004318681A1 (en) | Nucleic acid based assays for identification of FC receptor polymorphisms | |
KR101724130B1 (ko) | 장 베체트병 진단용 바이오마커 및 이의 용도 | |
JP2008529523A (ja) | 一塩基多型を含む乳癌に関連したポリヌクレオチド、それを含むマイクロアレイ及び診断キット、並びにそれを利用した乳癌の診断方法 | |
JP6128654B2 (ja) | 関節リウマチの新規遺伝因子としてのミエリン塩基性蛋白の利用 | |
JPWO2013157625A1 (ja) | Hla−a*24:02を検出する方法、及び検出キット | |
JP4657857B2 (ja) | メタボリックシンドロームの診断および予防 | |
MXPA06011476A (en) | Nucleic acid based assays for identification of fc receptor polymorphisms | |
KR102409336B1 (ko) | 면역글로불린 a 신병증 및 혈관염 진단용 snp 마커 및 이를 이용한 진단 방법 | |
AU2012261529A1 (en) | Methods and compositions for detecting BK virus | |
JP2006101847A (ja) | 気管支喘息の遺伝的素因検査方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC1 | Assignment before grant (sect. 113) |
Owner name: NOVARTIS VACCINES AND DIAGNOSTICS, INC. Free format text: FORMER APPLICANT(S): CHIRON CORPORATION |
|
TH | Corrigenda |
Free format text: IN VOL 22, NO 25, PAGE(S) 2951 UNDER THE HEADING ASSIGNMENTS BEFORE GRANT, SECTION 113 - 2004 UNDERTHE NAME NOVARTIS VACCINES AND DIAGNOSTICS, INC. DELETE ALL REFERENCE TO 2004318681 |
|
MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |